Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial

By Advani R. H.   Hoppe R. T.   Baer D.   Mason J.   Warnke R.   Allen J.   Daadi S.   Rosenberg S. A.   Horning S. J.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1044-1048

Oxford University Press

Access to resources Recommend Favorite

Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma

By Xu Yuanlin  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1396-1404

Informa Healthcare

Access to resources Recommend Favorite

Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

By Filippi Andrea Riccardo  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1183-1187

Informa Healthcare

Access to resources Recommend Favorite

Risk of second malignancies in patients with early‐stage classical Hodgkin's lymphoma treated in a modern era

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 513-518

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy

By Hodgson D.C.   Tsang R.W.   Pintilie M.   Sun A.   Wells W.   Crump M.   Gospodarowicz M.K.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 5, 2003-12 ,pp. : 1374-1381

Elsevier

Access to resources Recommend Favorite